Effect of Third Interstitial Fluid on Adverse Outcomes in Patients with Severe Pre-eclampsia and Twin Pregnancy: A 5-year Single-center Retrospective Study

Abstract

Objective

This study aims to identify the effect of third interstitial fluid on adverse outcomes in twin pregnancies with severe pre-eclampsia, and explore the differences in bad ending between twins and singletons.

Methods

The present retrospective cohort study was conducted on patients with severe pre-eclampsia, who delivered in Tongji Hospital, Wuhan, China, between 2017 and 2022. The adverse outcomes in singleton and twin pregnancies with severe pre-eclampsia were initially investigated. Then, the diverse maternal and fetal consequences between singleton and twin pregnancies in patients with severe pre-eclampsia were compared after merging with the third interstitial fluid.

Results

A total of 709 patients were included for the present study. Among these patients, 68 patients had twin pregnancies, and 641 patients had singleton pregnancies. The rate of postpartum hemorrhage (2.81% vs. 13.24%, P<0.001), and admission rate to the Neonatal Intensive Care Unit (NICU) after birth (30.73% vs. 63.24%, P=0.011) were significantly higher in twin pregnancies. The neonatal weight of twins was statistically lower than singletons (1964.73±510.61 g vs. 2142.92±731.25 g, P=0.008). For the groups with the third interstitial fluid, the delivery week (P=0.001) and rate of admission to the NICU after birth were significantly advanced in twin pregnancy group, when compared to singleton pregnancy group (P=0.032), and the length of hospital stay was shorter (P=0.044). Furthermore, there was no statistically significant difference between the twin pregnancy group and the singletony pregnancy group without the third interstitial fluid.

Conclusion

The maternal and fetal adverse outcomes of patients with severe pre-eclampsia increased in twin pregnancies, when compared to singleton pregnancies. Thus, when patients develop the third interstitial fluid, twin pregnancies would more likely lead to adverse fetal outcomes, when compared to singleton pregnancies, and there would be no significant difference in maternal adverse outcomes. More attention should be given to patients who merge with the third interstitial fluid.

Keywords

third interstitial fluid / twin pregnancies / severe pre-eclampsia / adverse outcome / risk factors

References

[1] Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin Summary, Number 222. Obstet Gynecol, 2020,135(6):1492–1495

[2] AvnonT, Ascher-LandsbergJ, YogevY, et al.. Clinical characteristics of preeclampsia in twin versus singleton pregnancies. J Matern Fetal Neonatal Med, 2022, 35(12): 2273-2277

[3] VitthalaS, GelbayaTA, BrisonDR, et al.. The risk of monozygotic twins after assisted reproductive technology: a systematic review and meta-analysis. Hum Reprod Update, 2009, 15(1): 45-55

[4] AbalosE, CuestaC, CarroliG, et al.. Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG, 2014, 121(Suppl1): 14-24

[5] StaffAC. The two-stage placental model of preeclampsia: An update. J Reprod Immunol, 2019, 134–135: 1-10

[6] NarangK, SzymanskiLM. Multiple Gestations and Hypertensive Disorders of Pregnancy: What Do We Know?. Curr Hypertens Rep, 2020, 23(1): 1

[7] de HaasS, Ghossein-DohaC, van KuijkSM, et al.. Physiological adaptation of maternal plasma volume during pregnancy: a systematic review and meta-analysis. Ultrasound Obstet Gynecol, 2017, 49(2): 177-187

[8] BrownMA, ZammitVC, MitarDM. Extracellular fluid volumes in pregnancy-induced hypertension. J Hypertens, 1992, 10(1): 61-68

[9] GyselaersW, VonckS, StaelensAS, et al.. Body fluid volume homeostasis is abnormal in pregnancies complicated with hypertension and/or poor fetal growth. PLoS One, 2018, 13(11): e0206257

[10] BrownMA, MageeLA, KennyLC, et al.. International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertensive Disorders of Pregnancy: ISSHP Classification, Diagnosis, and Management Recommendations for International Practice. Hypertension, 2018, 72(1): 24-43

[11] ConnollyKA, FactorSH, GetrajdmanCS, et al.. Maternal clinical disease characteristics and maternal and neonatal outcomes in twin and singleton pregnancies with severe preeclampsia. Eur J Obstet Gynecol Reprod Biol, 2016, 201: 36-41

[12] BlitzMJ, YukhayevA, PachtmanSL, et al.. Twin pregnancy and risk of postpartum hemorrhage. J Matern Fetal Neonatal Med, 2020, 33(22): 3740-3745

[13] BienstockJL, EkeAC, HueppchenNA. Postpartum Hemorrhage. N Engl J Med, 2021, 384(17): 1635-1645

[14] EndeHB, LozadaMJ, ChestnutDH, et al.. Risk Factors for Atonic Postpartum Hemorrhage: A Systematic Review and Meta-analysis. Obstet Gynecol, 2021, 137(2): 305-323

[15] LuoQG, ZhangJY, ChengWW, et al.. Is gestational hypertension protective against perinatal mortality in twin pregnancies?. PLoS One, 2014, 9(4): e94865

[16] LuoZC, SimonetF, AnN, et al.. Effect on neonatal outcomes in gestational hypertension in twin compared with singleton pregnancies. Obstet Gynecol, 2006, 108(5): 1138-1144

[17] American College of ObstetriciansGynecologists’ Committee on Practice Bulletins—ObstetricsSociety for Maternal-Fetal Medicine. Multifetal Gestations: Twin, Triplet, and Higher-Order Multifetal Pregnancies: ACOG Practice Bulletin, Number 231. Obstet Gynecol, 2021, 137(6): e145-e162

[18] Practice Committee of the American Society for Reproductive Medicine. Electronic address: [e-mail]; Practice Committee of the American Society for Reproductive Medicine. Performing the embryo transfer: a guideline. Fertil Steril, 2017, 107(4): 882-896

[19] PlattMJ. Outcomes in preterm infants. Public Health, 2014, 128(5): 399-403

[20] BrownHK, SpeechleyKN, MacnabJ, et al.. Neonatal morbidity associated with late preterm and early term birth: the roles of gestational age and biological determinants of preterm birth. Int J Epidemiol, 2014, 43(3): 802-814

[21] WuP, HaththotuwaR, KwokCS, et al.. Preeclampsia and Future Cardiovascular Health: A Systematic Review and Meta-Analysis. Circ Cardiovasc Qual Outcomes, 2017, 10(2): e003497

[22] YangY, Le RayI, ZhuJ, et al.. Preeclampsia Prevalence, Risk Factors, and Pregnancy Outcomes in Sweden and China. JAMA Netw Open, 2021, 4(5): e218401

[23] JohnsonJD, LouisJM. Does race or ethnicity play a role in the origin, pathophysiology, and outcomes of preeclampsia? An expert review of the literature. Am J Obstet Gynecol, 2022, 226(2S): S876-S885

[24] StaffAC. The two-stage placental model of preeclampsia: An update. J Reprod Immunol, 2019, 134–135: 1-10

[25] AntwiE, Amoakoh-ColemanM, VieiraDL, et al.. Systematic review of prediction models for gestational hypertension and preeclampsia. PLoS One, 2020, 15(4): e0230955

[26] DimitriadisE, RolnikDL, ZhouW, et al.. Pre-eclampsia. Nat Rev Dis Primers, 2023, 9(1): 8

[27] WitteveenT, Van Den AkkerT, ZwartJJ, et al.. Severe acute maternal morbidity in multiple pregnancies: a nationwide cohort study. Am J Obstet Gynecol, 2016, 214(5): 641.e1-641.e10

[28] GyselaersW, VonckS, StaelensAS, et al.. Gestational hypertensive disorders show unique patterns of circulatory deterioration with ongoing pregnancy. Am J Physiol Regul Integr Comp Physiol, 2019, 316(3): R210-R221